Revealed an alteration related to the loss of effectiveness of a treatment in lung cancer
The Cancer Genetics Group of the Josep Carreras Leukaemia Research Institute, led by Montse Sánchez-Céspedes, together with Luis Montuenga from CIMA, and Enriqueta Felip from Vall d'Hebron Hospital, has revealed that inactivation ...
Jan 23, 2020
0
57